The revised prices will apply to approximately 1,000 drugs listed under the National List of Essential Medicines. Price ...

Beginning April 1, prices for essential drugs like painkillers, antibiotics, and anti-diabetic medicines will rise by 1.74%.

Essential medicines for managing conditions like diabetes, cancer, heart disease, and bacterial infections such as painkillers, antibiotics, anti-infectives, anti-diabetics and cancer drugs are set to ...

Global Animal Health Market is expected to grow at a rate of 8-9% by 2029. Growing awareness of animal health products, ...

Recce Pharmaceuticals has entered global clinical trials with a product that could be a game changer for the medical industry ...

National Pharmaceutical Pricing Authority has authorized this price hike for approximately 1,000 drugs listed in the NLEM.

In a major development that could affect the many patients suffering from serious illnesses, prices of crucial drugs used to ...

Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 ...

Engineered frog-derived peptides may become powerful new antibiotics, showing strong results against resistant bacteria in ...

Mumbai: Global pharmaceutical giant Lupin has announced the retirement of its three senior executives.Naresh Gupta, President ...

The WHO’s 2025 report highlights global disparities in the detection of substandard and falsified medical products, ...

GSK is paying $90 million upfront for rights to the drug, with another $503 million on the table if Brexafemme achieves regulatory and commercial objectives, as well as royalties of between 5% and ...